Cytokinetics

CYTK

NASDAQHealth Care

Income Statement

Total Revenue$18.47M

Gross Profit$18.47M

Operating Income$-536.25M

EBITDA$-542.29M

EBIT$-551.83M

Pre-tax Income$-829.61M

Net Income$-589.53M

Cash Equivalent$112.97M

Total Debt$780.85M

Book Value$-109.22M

Book Value Per Share-0.99

Return on Equity (ROE)-88.27%

Return on Assets (ROA)-42.06%

Return on Invested Capital (ROI)-55.49%

Net Profit Margin-3191.11%

Current Ratio6.17

Quick Ratio6.08

Long-Term Debt / Equity0.59